Esperion Therapeutics, the leading developer of small molecule therapies for the treatment of cardiometabolic disorders, announced that Tim Mayleben has been named president and CEO of the company.
- Car Chronicles Blog – Cars, Kids and Common Sense May 18, 2013
- The Reunion Project – Friday Fun (5/17) May 17, 2013
- Trey Burke Talks Fab Five, Detroit Pistons With Ryan Wooley May 13, 2013
- Leach’s Lists: Three Keys For The Red Wings To Win Game 7 May 11, 2013